http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa4d5cfbefb183ef405a98c81ea9210a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hayashi |
| name | Hidetoshi Hayashi |
| given-name | Hidetoshi |
| organization-name | Graduate School of Pharmaceutical Sciences, Nagoya City University. Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University; Department of Innovative Therapeutics Sciences, Cooperative Major in Nanopharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan Department of Medical Oncology, Kindai University, Osaka, 589-8511, Japan. Department of Medical Oncology, Kindai University, Osakasayama City, Japan. Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences, Nagoya City University, Mizuho, Nagoya 467-8603, Japan. 5Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan. Department of Genome Biology, Faculty of Medicine Kinki University Osaka Japan Faculty of Pharmaceutical Sciences The University of Tokyo 7‐3‐1 Hongo, Bunkyo‐ku Tokyo 113 Japan; Faculty of Pharmaceutical Sciences Nagoya City University 7‐3‐1 Tanabe‐dori, Mizuho‐ku Nagoya 467 Japan Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan. Kindai University Faculty of Medicine, Osaka, Japan Department of Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Mizuho-cho, Nagoya, Aichi, Japan Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University Kinki University Faculty of Medicine 377-2, Ohno-Higashi, Osaka-Sayama-City, Osaka, Japan Hidetoshi Hayashi, MD, PhD; Kazuto Nishio, PhD; and Kazuhiko Nakagawa, MD, Kindai University, Osaka-Sayama, Japan Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan Department of Drug Metabolism and Disposition, Graduate School of Pharmaceutical Sciences, Nagoya City University Authors' Affiliations: Departments of 1Medical Oncology and 2Genome Biology, Kinki University Faculty of Medicine, Osaka-Sayama, Osaka; and 3National Hospital Organization Minamiwakayama Medical Center, Tanabe, Wakayama, Japan Department of Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Mizuho, Nagoya 467-8603, Japan Center for Clinical and Translational Research, Kyushu University Hospital, 3-1-1 Maidashi, Higashiku, Fukuoka 812-8582, Japan. [email protected]. Kaoru Kubota, Nippon Medical School; Kaori Hara and Takayuki Asato, Takeda Pharmaceutical, Tokyo; Hiroshige Yoshioka, Kurashiki Central Hospital, Kurashiki; Fumihiro Oshita, Kanagawa Prefectural Ashigarakami Hospital, Matsuda; Toyoaki Hida, Aichi Cancer Center Hospital, Nagoya; Kiyotaka Yoh, National Cancer Center Hospital East, Chiba; Hidetoshi Hayashi, Hiroyasu Kaneda, and Kazuhiko Nakagawa, Kindai University Faculty of Medicine; Hidetoshi Hayashi, Kishiwada Municipal Hospital, Osaka; Terufumi Kato,... Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan Department of Medical Oncology, Kindai University, Osakasayama, Japan Department of Genome Biology, Kinki University Faculty of Medicine, Osaka, Japan Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan Department of Medical Oncology, Kishiwada Municipal Hospital, Osaka, Japan. Department of Medical Oncology Kindai University Faculty of Medicine Osaka Japan Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences Nagoya City University Aichi Nagoya 467 Japan Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan Department of Drug Metabolism and Disposition, Graduate School of Pharmaceutical Sciences, Nagoya City University, Mizuho-ku, Nagoya 467-8603, Japan. Department of Medical Oncology Kindai University Hospital Osaka Japan Department of Molecular Health Sciences Graduate School of Pharmaceutical Sciences, Nagoya City University Aichi Nagoya 467‐8603 Japan Department of Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Mizuho, Nagoya, Japan. Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka 589‑8511, Japan Department of Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University , Japan Department of Cell Signaling Graduate School of Pharmaceutical Sciences Nagoya City University Japan; Department of Innovative Therapeutics Sciences Cooperative Major in Nanopharmaceutical Sciences Graduate School of Pharmaceutical Sciences Nagoya City University Japan Department of Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences, Nagoya City University, Mizuho, Nagoya 467-8603, Japan Department of Medical Oncology Kishiwada City Hospital Osaka Japan Department of Medical Oncology Kinki University Faculty of Medicine Osaka‐Sayama Osaka Japan Department of Genome Biology Kinki University Faculty of Medicine Osaka Japan Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka‑Sayama, Osaka 589‑8511, Japan Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka-Sayama, Osaka, Japan. Department of Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University , Nagoya , Japan Genome Biology, Kinki University Faculty of Medicine, Osaka, Japan. Department of Genome Biology, Kinki University Faculty of Medicine, Osakasayama City, Osaka, Japan; Department of Medical Oncology, Kinki University Faculty of Medicine, Osakasayama City, Osaka, Japan; Department of Medical Oncology, Kishiwada Municipal Hospital, Kishiwada, Osaka, Japan Kindai University Faculty of Medicine, Osaka-Sayama, Japan Faculty of Pharmaceutical Sciences The University of Tokyo 7‐3‐1, Hongo, Bunkyo‐ku Tokyo 113 Department of Medical Oncology Kindai University Faculty of Medicine Osaka‐Sayama Japan Kinki University Faculty of Medicine, Osaka, Japan Department of Genome Biology; Kinki University School of Medicine; Osaka-Sayama Osaka Japan; Department of Medical Oncology; Kinki University School of Medicine; Osaka-Sayama Osaka Japan Faculty of Medicine Kindai University Osaka Japan Department of Genome Biology, Kinki University School of Medicine. Department of Health Chemistry, Faculty of Pharmaceutical Sciences The University of Tokyo 7‐3‐1, Hongo, Bunkyoku Tokyo 113 Japan Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan Department of Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University Department of Medical Oncology Kindai University Faculty of Medicine Osaka‐Sayama, Osaka Japan Department of Respiratory Medicine, Kurashiki Central Hospital. Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan Department of Medical Oncology, Kindai University Faculty of Medicine , Osaka , Japan Kindai University Hospital Osaka Japan Faculty of Pharmaceutical Sciences University of Tokyo Hongo, Bunkyo‐ku Tokyo 113 Japan; Faculty of Pharmaceutical Sciences Nagoya City University Nagoya 467 Japan Nagoya City University Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, , 3-1 Tanabe-dori, Mizuho-ku, Nagoya 467-8603, Japan 1Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan. Department of Genome Biology, Kinki University Faculty of Medicine, Osaka-Sayama, Osaka, Japan Department of Respiratory Medicine, Kurashiki Central Hospital Department of Cell Signaling, Nagoya City University Graduate School of Pharmaceutical Sciences, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi, 467-8603, Japan; Department of Innovative Therapeutic Sciences, Cooperative Major in Nanopharmaceutical Sciences, Nagoya City University Graduate School of Pharmaceutical Sciences, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi, 467-8603, Japan Department of Drug Metabolism and Disposition, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan; Dept. of Medical Oncology, Kindai University, Faculty of Medicine. *Department of Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan; Department of Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Japan. Department of Genome Biology Kindai University Faculty of Medicine Osaka‐Sayama Osaka Japan; Department of Medical Oncology Kindai University Faculty of Medicine Osaka‐Sayama Osaka Japan Department of Medical Oncology *Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences, Nagoya City University, Mizuho, Nagoya, Japan; 1Department of Genome Biology, Kinki University Faculty of Medicine, Osaka, Japan. |
Incoming Links
Showing number of triples: 1 to 318 of 318.